Canada markets closed

Nuvo Pharmaceuticals Inc. (MRVFF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.9700-0.0030 (-0.31%)
At close: 10:16AM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.9730
Open0.9700
BidN/A x N/A
AskN/A x N/A
Day's Range0.9700 - 0.9700
52 Week Range0.4200 - 1.2500
Volume11,000
Avg. Volume6,406
Market Cap11.046M
Beta (5Y Monthly)0.84
PE Ratio (TTM)N/A
EPS (TTM)-0.9640
Earnings DateMar 27, 2023 - Mar 31, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    Miravo Healthcare™ Enters into Definitive Agreement to be Acquired by Searchlight Pharma Inc.

    MISSISSAUGA, Ontario & MONTREAL, Quebec, December 23, 2022--Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) ("Miravo" or the "Company") and Searchlight Pharma Inc., a private Canadian-based specialty healthcare company ("Searchlight" or the "Purchaser"), are pleased to announce that they have entered into a definitive agreement (the "Arrangement Agreement") pursuant to which the Purchaser has agreed to acquire all of the issued and outstanding common shares of the Compan

  • Business Wire

    Miravo Healthcare™ Announces Third Quarter 2022 Results

    MISSISSAUGA, Ontario, November 14, 2022--Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced its financial and operational results for the three and nine months ended September 30, 2022. For further details on the results, please refer to Miravo’s Management, Discussion and Analysis (MD&A) and Condensed Consolidated Interim Fina

  • Business Wire

    Miravo Healthcare™ Announces Third Quarter 2022 Results Release Date and Conference Call Details

    MISSISSAUGA, Ontario,, October 31, 2022--Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, today announced it expects to release its third quarter 2022 financial results before markets open on Monday, November 14, 2022.